Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 1 de 1
Filtrar
Mais filtros


Bases de dados
Ano de publicação
Tipo de documento
Intervalo de ano de publicação
1.
Am J Trop Med Hyg ; 74(5): 868-79, 2006 May.
Artigo em Inglês | MEDLINE | ID: mdl-16687695

RESUMO

Erythema nodosum leprosum (ENL) or type 2 lepra reactions complicate lepromatous leprosy and borderline lepromatous leprosy. We report an 11-year retrospective case record analysis of 481 outpatients with borderline lepromatous and lepromatous leprosy at the Dhoolpet Leprosy Research Center in Hyderabad, India.. The overall prevalence of ENL was 24%, 49.4% among cases of lepromatous leprosy (LL) and 9% among cases of borderline lepromatous (BL) leprosy. Logistic regression analysis identified LL (odds ratio [OR] = 8.4, 95% confidence interval [CI] = 4.6-15.4, P < 0.001) and BL with a bacterial index > or = 4+ (OR = 5.2, 95% CI = 2.1-12.9, P = 0.001) as major risk factors. The average patient with ENL was male, 34.7 years of age, and had multiple episodes of ENL (mean = 3.1) over an 18.5-month period. Three types of ENL were identified: single acute ENL, multiple acute ENL (repeated discrete episodes), and chronic ENL (continuous episodes). Acute single ENL is rare, accounting for only 8% of cases. Chronic ENL accounted for 62.5% of the cohort. Chronic ENL was of longer duration and more severe. An age > or = 35 years was a risk factor for developing chronic ENL. Patients with chronic ENL were more compliant with multi-drug therapy, especially during the first six doses of multi-drug therapy. Distinguishing these different types of ENL would be useful for patient management and developing improved treatment of these debilitating reactions. Improved strategies for treatment and management of these reactions need to be developed.


Assuntos
Eritema Nodoso/epidemiologia , Hanseníase Dimorfa/epidemiologia , Hanseníase Virchowiana/epidemiologia , Adulto , Estudos de Coortes , Eritema Nodoso/etiologia , Eritema Nodoso/patologia , Eritema Nodoso/prevenção & controle , Feminino , Humanos , Índia/epidemiologia , Hanseníase Dimorfa/etiologia , Hanseníase Dimorfa/patologia , Hanseníase Dimorfa/prevenção & controle , Hanseníase Virchowiana/etiologia , Hanseníase Virchowiana/patologia , Hanseníase Virchowiana/prevenção & controle , Modelos Logísticos , Masculino , Prontuários Médicos , Prevalência , Estudos Retrospectivos , Fatores de Risco , Índice de Gravidade de Doença
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA